A 36-year-old man was admitted to our hospital with polyuria and polydipsia, mild headaches, dizziness, fatigue and general weakness since 4 weeks. There were no other specific symptoms reported by the patient. His medical history did not reveal any previous diseases or disorders. Physical and neurological examinations were adequate. The polyuria and polydipsia in combination with low urine osmolality (102 mosm/kg) were highly suggestive of diabetes insipidus (DI). Therefore, a water restriction test was performed. It was terminated after 12 h due to urine output of 5 l and 7 % loss of body weight. With water deprivation, diuresis and low urine osmolality persisted (105 mosmol/kg at baseline and 214 mosmol/kg at termination) and serum sodium levels rose from 145 mmol/l to 154 mmol/l. Intranasal application of desmopressin 10 µg normalized serum sodium as well as hourly urine output, urine osmolality rose to 518 mosmol/kg confirming the diagnosis of central DI. Urine routine tests and urinary sediment analysis did not show abnormalities. A diabetes mellitus type 2 was ruled out. Assessment of his anterior pituitary function showed baseline 09:00 cortisol of 286 nmol/l and adrenocorticotropin of 16.4 pg/ml (RR: 7.2-63.3 pg/ml). An ACTH-test with Stimulation with 250 µg tetracosactrin demonstrated an increase in serum cortisol to 921 nmol/l indicating a normal adrenocortical reserve. A normal level of thyroid stimulating hormone (TSH) of 0.96 µU/ml (RR: 0.27-4.20 µU/ml) and free thyroxin (fT4)
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A 36-year-old man was admitted to our hospital with polyuria and polydipsia, mild headaches, dizziness, fatigue and general weakness since 4 weeks. There were no other specific symptoms reported by the patient. His medical history did not reveal any previous diseases or disorders. Physical and neurological examinations were adequate. The polyuria and polydipsia in combination with low urine osmolality (102 mosm/kg) were highly suggestive of diabetes insipidus (DI). Therefore, a water restriction test was performed. It was terminated after 12 h due to urine output of 5 l and 7 % loss of body weight. With water deprivation, diuresis and low urine osmolality persisted (105 mosmol/kg at baseline and 214 mosmol/kg at termination) and serum sodium levels rose from 145 mmol/l to 154 mmol/l. Intranasal application of desmopressin 10 µg normalized serum sodium as well as hourly urine output, urine osmolality rose to 518 mosmol/kg confirming the diagnosis of central DI. Urine [1] [2] [3] [4] [5] [6] [7] [8] [9] . Pituitary involvement in GPA predominantly affects the posterior pituitary gland resulting in central diabetes insipidus (DI) but global or partial anterior pituitary dysfunction and compression of the optic chiasm has also been described (10) . Relapse and permanent residual pituitary insufficiency is common despite immunosuppressive therapy [7] . Vasculitis of the pituitary gland without manifestation in other organs has been described in few patients and diagnosis of GPA was attained by the presence of proteinase-3 specific ANCA and/or transsphenoidal biopsy in these cases [10] [11] [12] . The case presented here demonstrates that pauci-immune vasculitis of the pituitary can occur in the absence of systemic disease. The diagnosis can be made by stereotactic biopsy but therapy remains a challenge.
License terms
10.7 (RR: 10.6-22.7 pmol/l) was documented. Triiodothyronine (fT3) was low at 3.11 pmol/l (RR: 3.4-6.8 pmol/l). Regular thyreotropic function was confirmed by a TRH (thyrotropin releasing hormone) test: Intravenous administration of 200 µg TRH increased the baseline TSH from 1.44 µU/ml to 7.09 µU/ml after 30 min. The morning testosterone level was low in repeated measurements (6.98-8.13 nmol/l, RR: 8.64-29.0 nmol/l) and partial insufficiency of the gonadotropic axis was proven by a GnRH-test (gonadotropin-releasing hormone). 100 µg of intravenous GnRH prompted an adequate increase of luteinizing hormone (LH) from 3.5 to 11.4 mIU/ml (RR: 1.7-8.6 mIU/ml) after 30 min. The increment of testosterone (6.17-6.01 nmol/, RR: 8.64-29.0 nmol/l) and follicle stimulating hormone (FSH) (1.6-2.2 mIU/ml, RR: 1.5-12.4 mIU/ml) after 30 min was low. Substitution of testosterone 25 mg daily was initiated. Prolactin was within normal range with 286 µIU/ml (RR: 86-324 µIU/ml), IGF-1 was also in normal range with 163 ng/ml /RR 109-284 ng/ml). Serologic testing for antinuclear antibodies (ANA), anti-double stranded DNA (anti-dsDNA) antibodies, anti-phospholipid antibodies, myeloperoxidase-and proteinase 3 specific anti-neutrophil cytoplasmic antibodies (ANCA) was negative. Complement components C3, C4, and complement split product C3d were within normal ranges. Total hemolytic complement activity measured by CH50 was within normal limits. A high resolution computed tomography of the chest showed no abnormalities. Thus, a diagnosis of a systemic vasculitis, especially GPA (Wegener's granulomatosis) in which pituitary involvement has been described before, was unlikely. Analysis of cerebrospinal fluid (CSF) obtained by lumbar puncture showed a cell count of 2 per µl with 90 % lymphocytes, 10 % monocytes and an elevated CD4/ CD8 ratio of 5.3. Protein (630 mg/l) and lactate (1.36 mmol/l) levels were marginally higher than normal. There were no signs of local synthesis of immunoglobulins. The patients' serum showed normal Interleukin-2 receptor (266 U/ml), neopterin (5.6 nmol/l) and angiotensin-converting enzyme (28.7 U/l) concentrations making a diagnosis of neurosarcoidosis improbable. A cranial MRI revealed a single Gadolinium-enhancing nodule of 8 × 6 × 7 mm at the pituitary stalk ( • ▶ Fig. 1) . No abnormalities of the paranasal sinuses were present. A stereotactic biopsy via a right frontal trajectory was performed using a Leksell stereotaxy system and a 2.1 mm side-cutting biopsy needle. Hematoxylin-eosin stained formalin-fixed and paraffin-embedded sections of the stereotactic biopsy material showed dense perivascular as well as intraparenchymal mononuclear infiltrates ( • ▶ Fig. 2a, b) . These infiltrates were embedded in a loose glial matrix exhibiting distinct astrogliosis as seen in the GFAP stain ( • ▶ Fig. 2c) . ▶ Fig. 2d, e) and several CD20-positive B cells ( • ▶ Fig. 2f ).
Only single CD8-positive cells could be detected within the infiltrates ( • ▶ Fig. 2g) . Few plasma cells reacting positive in the CD138 immunohistochemical staining as well as immature B cells staining positive for CD79a were observed. Several CD68-positive macrophages were present. Staining for components of the complement system (C1q, C3c, C4d, C5b-9), IgG and IgG4 subclass were negative (not shown). The small blood vessel walls were fragmented, a characteristic hallmark of vasculitis, as seen clearly in the Tibor Pap Silver staining ( • ▶ Fig. 2h) . Cloddy myelin loss ( • ▶ Fig. 2i ) as well as axonal damage could be detected in the myelin basic protein (MBP) and Bielschowsky silver staining, respectively. Mitotic figures were absent and MIB1 staining (against the Ki-67 antigen), in which only few hematopoietic cells were marked positively, confirmed low proliferative activity. Special stains for the protozoan Toxoplasma gondii and various viruses (i. e., EBV, CMV, HSV1 and HSV2) were negative in the available specimens. Pituitary gland tissue was not detectable in the stereotactic biopsy material. In summary, the histomorphological as well as immunohistochemical findings allowed for the diagnosis of vasculitis accompanied by secondary myelin loss and axonal damage. There was no evidence of a malignant neoplastic proliferative process. A treatment with methylprednisolone and azathioprine (AZA) was initiated and AZA was gradually increased to a daily dose of 150 mg per day. MRI follow-up 10 weeks after AZA had been started showed no change of the lesion at the pituitary stalk. As we were not sure whether AZA was given long enough to reach its effect methylprednisolone dose was increased to 1 mg/kg for one week and then tapered within 5 weeks to a maintenance dose of 5 mg/d. However, MRI follow-up 6 and 8 months after diagnosis showed no response. We advocated a change of the therapeutic regimen to Rituximab but the patient refused further treatment other than hormone replacement. Diabetes insipidus and secondary hypogonadism persisted, but the patient did well under hormone replacement therapy with testosterone and desmopressin.
Discussion

▼
Pituitary involvement in systemic vasculitis is extremely rare and most cases have been described in GPA [3-5, 7, 10,13,14] . Predominantly the posterior pituitary is affected causing central DI but partial or total anterior pituitary dysfunction can be present. Although the pituitary can be the first organ affected by GPA and diabetes insipidus may be the presenting symptom, systemic involvement was present or ensued in all cases of pituitary vasculitis reported to date [7, 15] . The patient presented here is, to the best of our knowledge, the first reported case of a vasculitis of the pituitary without systemic disease. Lack of immune-complex deposition ("pauci-immune") is typical for the ANCA-associated vasculitides like GPA or MPA. As in the patient we report a pauci-immune vasculitis was diagnosed on histologic examination, we suspect a localized form of GPA or MPA in the patient. The patient was ANCA negative, but localized disease stages of GPA and MPA often lack ANCAs in peripheral blood. The differential diagnoses for pituitary gland lesions are broad. Pituitary gland lesions can take both an expansive and/or invasive course. As destruction of the surrounding tissue rapidly leads to severe neurological deficits (vision loss, anterior pituitary insufficiency) initiation of the correct treatment is of outmost importance. We demonstrate here that it is feasible to establish the diagnosis of an isolated vasculitis of the pituitary stalk by stereotactic biopsy. The patient was started on a combined immunosuppressive treatment with azathioprine and glucocorticoids. However, follow-up MRI 6 and 8 months after diagnosis showed no response. Kapoor et al. recently reported good remission rates of DI and poor remission rates for anterior pituitary function in their series of 8 patients. Interestingly, this was independent from morphological response of the pituitary lesions on MRI [10] . In line with most published cases, our patient did not regain pituitary function as DI and secondary hypogonadism persisted [7] . Unfortunately, the patient is refusing a therapy with the B-cell depleting monoclonal antibody Rituximab (RTX). RTX has been proven to be effective in ANCAassociated vasculitis in a randomized, placebo-controlled trial and was effective in the treatment of several patients with pituitary involvement of GPA that did not respond to cyclophosphamide [10,13,14].
Conclusion ▼
Vasculitis of the pituitary gland causing pituitary insufficiency was previously reported as a rare manifestation of systemic vasculitis, mainly in GPA. Serologic markers and the presence of further organ involvement can help to establish the diagnosis in systemic vasculitis. Unfortunately, diagnosing a limited, localized variant of vasculitides remains extremely challenging. The case reported here demonstrates that isolated vasculitis of the pituitary can occur in the absence of systemic disease. In this setting, stereotactic biopsy can pave the way to diagnosis and help to timely initiate therapy. Azathioprine and steroids did not induce remission in our patient. We strongly suggest a therapy with Rituximab.
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